Blair Weig

850 total citations
20 papers, 711 citations indexed

About

Blair Weig is a scholar working on Endocrine and Autonomic Systems, Nutrition and Dietetics and Molecular Biology. According to data from OpenAlex, Blair Weig has authored 20 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrine and Autonomic Systems, 9 papers in Nutrition and Dietetics and 8 papers in Molecular Biology. Recurrent topics in Blair Weig's work include Regulation of Appetite and Obesity (10 papers), Receptor Mechanisms and Signaling (8 papers) and Biochemical Analysis and Sensing Techniques (8 papers). Blair Weig is often cited by papers focused on Regulation of Appetite and Obesity (10 papers), Receptor Mechanisms and Signaling (8 papers) and Biochemical Analysis and Sensing Techniques (8 papers). Blair Weig collaborates with scholars based in United States, United Kingdom and Japan. Blair Weig's co-authors include Brian E. Hawes, Michael P. Graziano, Kim O’Neill, John W. Clader, Steven D.E. Fried, Timothy J. Kowalski, Brian D. Spar, William J. Greenlee, Mark D. McBriar and Anandan Palani and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Blair Weig

19 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blair Weig United States	14	320	241	200	186	125	20	711
Michael Ankersen Denmark	16	399 1.2×	586 2.4×	432 2.2×	147 0.8×	209 1.7×	38	1.2k
Akira Gomori Japan	17	308 1.0×	498 2.1×	274 1.4×	148 0.8×	100 0.8×	25	1.1k
Stéphane St-Onge Canada	13	367 1.1×	193 0.8×	136 0.7×	270 1.5×	53 0.4×	18	702
Bridget Butler United States	15	279 0.9×	477 2.0×	215 1.1×	156 0.8×	147 1.2×	30	1.1k
Beth A. Fleck United States	19	400 1.3×	378 1.6×	341 1.7×	135 0.7×	205 1.6×	51	910
Maristella Adami Italy	16	355 1.1×	92 0.4×	36 0.2×	124 0.7×	301 2.4×	57	1.1k
Shu‐Gui Huang United States	16	393 1.2×	133 0.6×	105 0.5×	56 0.3×	19 0.2×	22	765
Jun‐ichi Eiki Japan	17	791 2.5×	230 1.0×	89 0.4×	51 0.3×	125 1.0×	28	1.3k
Lakmal W. Boteju United States	11	324 1.0×	99 0.4×	41 0.2×	176 0.9×	172 1.4×	20	533
Lakshmipathi Pandarinathan United States	15	311 1.0×	37 0.2×	63 0.3×	147 0.8×	84 0.7×	22	773

Countries citing papers authored by Blair Weig

Since Specialization

Citations

This map shows the geographic impact of Blair Weig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blair Weig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blair Weig more than expected).

Fields of papers citing papers by Blair Weig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blair Weig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blair Weig. The network helps show where Blair Weig may publish in the future.

Co-authorship network of co-authors of Blair Weig

This figure shows the co-authorship network connecting the top 25 collaborators of Blair Weig. A scholar is included among the top collaborators of Blair Weig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blair Weig. Blair Weig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hossain, Muhammad M., Blair Weig, Kenneth R. Reuhl, et al.. (2018). The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6. Experimental Neurology. 308. 111–119. 36 indexed citations

Takahashi, Shogo, Naoki Tanaka, Tatsuki Fukami, et al.. (2017). Editor’s Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway. Toxicological Sciences. 158(2). 334–346. 19 indexed citations

Weig, Blair, Jason R. Richardson, Herbert E. Lowndes, & Kenneth R. Reuhl. (2016). Trimethyltin intoxication induces the migration of ventricular/subventricular zone cells to the injured murine hippocampus. NeuroToxicology. 54. 72–80. 2 indexed citations

Hyde, Lynn A., Cinzia Cantù, Xia Chen, et al.. (2012). P1‐232: Chronic BACE inhibition halts further age‐related increases in brain Aß and amyloid plaques in aged TgCRND8 mice with established plaques. Alzheimer s & Dementia. 8(4S_Part_5).

Su, Jing, Brian A. McKittrick, Tao Guo, et al.. (2007). Synthesis of novel bicyclo[4.1.0]heptane and bicyclo[3.1.0]hexane derivatives as melanin-concentrating hormone receptor R1 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(17). 4845–4850. 5 indexed citations

Su, Jing, Brian A. McKittrick, Duane A. Burnett, et al.. (2007). SAR study of bicyclo[4.1.0]heptanes as melanin-concentrating hormone receptor R1 antagonists: Taming hERG. Bioorganic & Medicinal Chemistry. 15(16). 5369–5385. 7 indexed citations

Xu, Ruo, Shengjian Li, Mark D. McBriar, et al.. (2006). Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists. Bioorganic & Medicinal Chemistry. 14(10). 3285–3299. 22 indexed citations

Wu, Wen‐Lian, Duane A. Burnett, Mary Ann Caplen, et al.. (2006). Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3674–3678. 12 indexed citations

Kowalski, Timothy J., Brian D. Spar, Blair Weig, et al.. (2006). Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. European Journal of Pharmacology. 535(1-3). 182–191. 44 indexed citations

10.

Li, Qiang, Duane A. Burnett, William J. Greenlee, et al.. (2006). Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases. Bioorganic & Medicinal Chemistry Letters. 16(20). 5427–5431. 15 indexed citations

11.

McBriar, Mark D., Henry Guzik, Sherry Shapiro, et al.. (2006). Discovery of Orally Efficacious Melanin-Concentrating Hormone Receptor-1 Antagonists as Antiobesity Agents. Synthesis, SAR, and Biological Evaluation of Bicyclo[3.1.0]hexyl Ureas. Journal of Medicinal Chemistry. 49(7). 2294–2310. 58 indexed citations

12.

Palani, Anandan, Sherry Shapiro, Mark D. McBriar, et al.. (2005). Biaryl Ureas as Potent and Orally Efficacious Melanin Concentrating Hormone Receptor 1 Antagonists for the Treatment of Obesity. Journal of Medicinal Chemistry. 48(15). 4746–4749. 54 indexed citations

13.

McBriar, Mark D., Henry Guzik, Ruo Xu, et al.. (2005). Discovery of Bicycloalkyl Urea Melanin Concentrating Hormone Receptor Antagonists: Orally Efficacious Antiobesity Therapeutics. Journal of Medicinal Chemistry. 48(7). 2274–2277. 65 indexed citations

14.

Fawzi, Ahmad, Douglas Macdonald, April Smith‐Torhan, et al.. (2001). SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors. Molecular Pharmacology. 59(1). 30–37. 66 indexed citations

15.

Wang, Suke, Kim O’Neill, Blair Weig, et al.. (2001). Identification and Pharmacological Characterization of a Novel Human Melanin-concentrating Hormone Receptor, MCH-R2. Journal of Biological Chemistry. 276(37). 34664–34670. 89 indexed citations

16.

17.

Hawes, Brian E., Steven D.E. Fried, Xiaorui Yao, Blair Weig, & Michael P. Graziano. (1998). Nociceptin (ORL‐1) and μ‐Opioid Receptors Mediate Mitogen‐Activated Protein Kinase Activation in CHO Cells Through a G_i‐Coupled Signaling Pathway: Evidence for Distinct Mechanisms of Agonist‐Mediated Desensitization. Journal of Neurochemistry. 71(3). 1024–1033. 63 indexed citations

18.

Fawzi, Ahmad, Hongtao Zhang, Blair Weig, Brian E. Hawes, & Michael P. Graziano. (1997). Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: Functional homology with opioid receptors. European Journal of Pharmacology. 336(2-3). 233–242. 38 indexed citations

19.

Rock, Fernando, D L Peterson, Blair Weig, Rob Kastelein, & J. Fernando Bazán. (1996). Binding of Leptin to the Soluble Ectodomain of Recombinant Leptin Receptor. Hormone and Metabolic Research. 28(12). 748–750. 20 indexed citations

20.

Salisbury, Brian, Harry R. Davis, Robert E. Burrier, et al.. (1995). Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis. 115(1). 45–63. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact